Abstract
Most cancers originate in a particular cell type within a tissue by accumulating both mutations and epigenetic changes that alter the hierarchical balance of cells within the affected tissue. These changes result in greater self-renewal and proliferation capacity and a tendency to immortalization at the expense of differentiation, senescence, and cell death. Over time, subpopulations of these aberrant cells break tissue boundaries, invade adjacent tissues, suppress the immune system, and spread to other parts of the body. These changes are associated with metabolic remodeling to support a predominantly glycolytic metabolism. This metabolic remodeling occurs while interacting with normal cells in the microenvironment including stromal, vascular, and neural cells and cells of the immune system. Complex tumor biology demands strategic therapeutic approaches that address different aspects of this biology simultaneously and that can be adapted to the ongoing changes in metabolism that underpin tumor progression.
A previous version of this chapter included an incorrect figure (Fig. 2.1. was represented incorrectly). For this reason an erratum has been published, correcting the mistake in the previous version and showing the correct figure (see DOI 10.1007/978-3-7091-1824-5_16).
The version readers currently see is the corrected version with the figure in chapter 2 shown correctly. The reader sees the chapter in its intended form. The Publisher would like to apologize for the earlier mistake.
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-3-7091-1824-5_16
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acin-Perez R, Fernandez-Silva P, Peleato ML, Perez-Martos A, Enriquez JA (2008) Respiratory active mitochondrial supercomplexes. Mol Cell 32:529–539
Ahmed N, Berridge MV (1999) Distinct regulation of glucose transport by interleukin-3 and oncogenes in a murine bone marrow-derived cell line. Biochem Pharmacol 57:387–396
Ahmed N, Berridge MV (1998) Transforming oncogenes regulate glucose transport by increasing transporter affinity for glucose: contrasting effects of oncogenes and heat stress in a murine marrow-derived cell line. Life Sci 63:1887–1903
Armstrong L, Tilgner K, Saretzki G, Atkinson SP, Stojkovic M, Moreno R et al (2010) Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 28:661–673
Aschrafi A, Schwechter AD, Mameza MG, Natera-Naranjo O, Gioio AE, Kaplan BB (2008) MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J Neurosci 28:12581–12590
Baccelli I, Trumpp A (2012) The evolving concept of cancer and metastasis stem cells. J Cell Biol 198:281–293
Bandiera S, Ruberg S, Girard M, Cagnard N, Hanein S, Chretien D et al (2011) Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One 6:e20746
Barrey E, Saint-Auret G, Bonnamy B, Damas D, Boyer O, Gidrol X (2011) Pre-microRNA and mature microRNA in human mitochondria. PLoS One 6:e20220
Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E et al (2010) SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 11:366–372
Berridge MV, Herst PM, Tan AS (2010) Metabolic flexibility and cell hierarchy in metastatic cancer. Mitochondrion 10:584–588
Berridge MV, Herst PM, Tan AS (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 11:127–152
Berridge MV, Tan AS (2010) Effects of mitochondrial gene deletion on tumorigenicity of metastatic melanoma: reassessing the Warburg effect. Rejuvenation Res 13:139–141
Berridge MV, Tan AS (2000) High-capacity redox control at the plasma membrane of mammalian cells: trans-membrane, cell surface, and serum NADH-oxidases. Antioxid Redox Signal 2:231–242
Bienertova-Vasku J, Sana J, Slaby O (2013) The role of microRNAs in mitochondria in cancer. Cancer Lett 336:1–7
Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737
Borodovsky A, Seltzer MJ, Riggins GJ (2012) Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2. Curr Opin Oncol 24:83–89
Brahimi-Horn C, Pouyssegur J (2006) The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull Cancer 93:E73–E80
Brand K (1997) Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J Bioenerg Biomembr 29:355–364
Burrell RA, McGranahan N, Bartek J, Swanton C (2013) The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501:338–345
Caramel J, Papadogeorgakis E, Hill L, Browne GJ, Richard G, Wierinckx A et al (2013) A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24:466–480
Chan YC, Banerjee J, Choi SY, Sen CK (2012) miR-210: the master hypoxamir. Microcirculation 19:215–223
Chen B, Li H, Zeng X, Yang P, Liu X, Zhao X et al (2012) Roles of microRNA on cancer cell metabolism. J Transl Med 10:228
Chen CT, Shih YR, Kuo TK, Lee OK, Wei YH (2008) Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 26:960–968
Cho YM, Kwon S, Pak YK, Seol HW, Choi YM, Park do J et al (2006) Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem Biophys Res Commun 348:1472–1478
Choi SY, Collins CC, Gout PW, Wang Y (2013) Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? J Pathol 230:350–355
Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R et al (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230–233
Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A (2007) Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med 4(Suppl 1):S60–S67
Crane FL, Sun IL, Barr R, Low H (1991) Electron and proton transport across the plasma membrane. J Bioenerg Biomembr 23:773–803
Croci DO, Zacarias Fluck MF, Rico MJ, Matar P, Rabinovich GA, Scharovsky OG (2007) Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother 56:1687–1700
Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D et al (2012) Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res 110:1596–1603
Debeb BG, Lacerda L, Xu W, Larson R, Solley T, Atkinson R et al (2012) Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/beta-catenin signaling. Stem Cells 30:2366–2377
DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11–20
del Castillo-Olivares A, Nunez de Castro I, Medina MA (2000) Dual role of plasma membrane electron transport systems in defense. Crit Rev Biochem Mol Biol 35:197–220
Denko NC (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8:705–713
Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R et al (2009) Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41:1350–1353
Facucho-Oliveira JM, St John JC (2009) The relationship between pluripotency and mitochondrial DNA proliferation during early embryo development and embryonic stem cell differentiation. Stem Cell Rev 5:140–158
Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao Y et al (2012) MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol Chem 287:23227–23235
Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9:425–434
Fei X, Qi M, Wu B, Song Y, Wang Y, Li T (2012) MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. FEBS Lett 586:392–397
Fiorentini D, Prata C, Maraldi T, Zambonin L, Bonsi L, Hakim G et al (2004) Contribution of reactive oxygen species to the regulation of Glut1 in two hemopoietic cell lines differing in cytokine sensitivity. Free Radic Biol Med 37:1402–1411
Flavahan WA, Wu Q, Hitomi M, Rahim N, Kim Y, Sloan AE et al (2013) Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. Nat Neurosci 16:1373–1382
Folmes CD, Arrell DK, Zlatkovic-Lindor J, Martinez-Fernandez A, Perez-Terzic C, Nelson TJ et al (2013) Metabolome and metaboproteome remodeling in nuclear reprogramming. Cell Cycle 12:2355–2365
Folmes CD, Dzeja PP, Nelson TJ, Terzic A (2012) Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell 11:596–606
Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP et al (2011) Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab 14:264–271
Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM (2006) MicroRNA expression and function in cancer. Trends Mol Med 12:580–587
Gill AJ (2012) Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology 44:285–292
Giudice FS, Pinto DS Jr, Nor JE, Squarize CH, Castilho RM (2013) Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer. PLoS One 8:e58672
Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305–318
Gui DY, Lewis CA, Vander Heiden MG (2013) Allosteric regulation of PKM2 allows cellular adaptation to different physiological states. Sci Signal 6:pe7
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Herst PM, Berridge MV (2013) Cell hierarchy, metabolic flexibility and systems approaches to cancer treatment. Curr Pharm Biotechnol 14:289–299
Herst PM, Berridge MV (2007) Cell surface oxygen consumption: a major contributor to cellular oxygen consumption in glycolytic cancer cell lines. Biochim Biophys Acta 1767:170–177
Herst PM, Berridge MV (2006) Plasma membrane electron transport: a new target for cancer drug development. Curr Mol Med 6:895–904
Herst PM, Tan AS, Scarlett DJ, Berridge MV (2004) Cell surface oxygen consumption by mitochondrial gene knockout cells. Biochim Biophys Acta 1656:79–87
Iommarini L, Calvaruso MA, Kurelac I, Gasparre G, Porcelli AM (2013) Complex I impairment in mitochondrial diseases and cancer: parallel roads leading to different outcomes. Int J Biochem Cell Biol 45:47–63
Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL et al (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8:143–153
Jiang S, Zhang LF, Zhang HW, Hu S, Lu MH, Liang S et al (2012) A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J 31:1985–1998
Kaplon J, Zheng L, Meissl K, Chaneton B, Selivanov VA, Mackay G et al (2013) A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 498:109–112
Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M et al (2013) Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov 3:648–657
Kim JW, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177–185
King A, Selak MA, Gottlieb E (2006) Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25:4675–4682
Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celia-Terrassa T et al (2011) Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 17:1101–1108
Krause DS, Crispino J (2013) Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia. Clin Cancer Res 19:6084–6088
Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S et al (2003) Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97:1015–1024
Kuo SZ, Blair KJ, Rahimy E, Kiang A, Abhold E, Fan JB et al (2012) Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt. BMC Cancer 12:556
Lallemand-Breitenbach V, Zhu J, Chen Z, de The H (2012) Curing APL through PML/RARA degradation by As2O3. Trends Mol Med 18:36–42
Lapuente-Brun E, Moreno-Loshuertos R, Acin-Perez R, Latorre-Pellicer A, Colas C, Balsa E et al (2013) Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science 340:1567–1570
Larman TC, DePalma SR, Hadjipanayis AG, Protopopov A, Zhang J, Gabriel SB et al (2012) Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci U S A 109:14087–14091
Letouze E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C et al (2013) SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 23:739–752
Liebig C, Ayala G, Wilks JA, Berger DH, Albo D (2009) Perineural invasion in cancer: a review of the literature. Cancer 115:3379–3391
Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ et al (2011) Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 43:869–874
Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ et al (2013) Autonomic nerve development contributes to prostate cancer progression. Science 341:1236361
Majmundar AJ, Wong WJ, Simon MC (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40:294–309
Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K et al (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361:1058–1066
Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP (2012) Ketone body utilization drives tumor growth and metastasis. Cell Cycle 11:3964–3971
Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Tanowitz HB, Sotgia F et al (2011) Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int J Biochem Cell Biol 43:1045–1051
Mason EF, Hornick JL (2013) Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis. Mod Pathol 26:1492–1497
Mathupala SP, Ko YH, Pedersen PL (2009) Hexokinase-2 bound to mitochondria: cancer’s stygian link to the “Warburg Effect” and a pivotal target for effective therapy. Semin Cancer Biol 19:17–24
Mazurek S (2011) Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 43:969–980
Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG et al (2010) Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle 9:2412–2422
Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E (2007) Energy metabolism in tumor cells. FEBS J 274:1393–1418
Nakashima RA, Paggi MG, Pedersen PL (1984) Contributions of glycolysis and oxidative phosphorylation to adenosine 5’-triphosphate production in AS-30D hepatoma cells. Cancer Res 44:5702–5706
Nemazanyy I, Espeillac C, Pende M, Panasyuk G (2013) Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expression. Biochem Soc Trans 41:917922
Palorini R, Votta G, Balestrieri C, Monestiroli A, Olivieri S, Vento R et al (2013) Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS. J Cell Biochem 115:368–379
Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187–197
Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812
Pattappa G, Heywood HK, de Bruijn JD, Lee DA (2011) The metabolism of human mesenchymal stem cells during proliferation and differentiation. J Cell Physiol 226:2562–2570
Pollard PJ, Wortham NC, Tomlinson IP (2003) The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. Ann Med 35:632–639
Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD et al (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20:291–293
Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K et al (2011) Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476:346–350
Prigione A, Adjaye J (2010) Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. Int J Dev Biol 54:1729–1741
Prigione A, Fauler B, Lurz R, Lehrach H, Adjaye J (2010) The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 28:721–733
Rakheja D, Medeiros LJ, Bevan S, Chen W (2013) The emerging role of d-2-hydroxyglutarate as an oncometabolite in hematolymphoid and central nervous system neoplasms. Front Oncol 3:169
Renault VM, Rafalski VA, Morgan AA, Salih DA, Brett JO, Webb AE et al (2009) FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 5:527–539
Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111
Scarlett D-JG, Herst PM, Tan AS, Prata C, Berridge MV (2004) Mitochondrial gene-knockout (ro) cells: a versatile model for exploring the secrets of trans-plasma membrane electron transport. Biofactors 20:213–220
Schon EA, DiMauro S, Hirano M (2012) Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet 13:878–890
Schornack PA, Gillies RJ (2003) Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. Neoplasia 5:135–145
Schulze A, Harris AL (2012) How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491:364–373
Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A et al (2009) Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461:809–813
Shaw RJ, Cantley LC (2012) Decoding key nodes in the metabolism of cancer cells: sugar & spice and all things nice. F1000 Biol Rep 4:2
Shyh-Chang N, Daley GQ, Cantley LC (2013) Stem cell metabolism in tissue development and aging. Development 140:2535–2547
Singh PK, Mehla K, Hollingsworth MA, Johnson KR (2011) Regulation of aerobic glycolysis by microRNAs in cancer. Mol Cell Pharmacol 3:125–134
Sproul D, Nestor C, Culley J, Dickson JH, Dixon JM, Harrison DJ et al (2011) Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc Natl Acad Sci USA 108:4364–4369
St John JC (2012) Transmission, inheritance and replication of mitochondrial DNA in mammals: implications for reproductive processes and infertility. Cell Tissue Res 349:795–808
Stewart TJ, Smyth MJ (2011) Improving cancer immunotherapy by targeting tumor-induced immune suppression. Cancer Metastasis Rev 30:125–140
Suda T, Takubo K, Semenza GL (2011) Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 9:298–310
Sun Q, Chen X, Ma J, Peng H, Wang F, Zha X et al (2011) Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci USA 108:4129–4134
Tan AS, Baty J, Berridge MV (2013) The role of mitochondrial electron transport in tumorigenesis and metastasis. Biochim Biophys Acta 1840:1454–1463
Tan AS, Berridge MV (2004) Distinct trans-plasma membrane redox pathways reduce cell-impermeable dyes in HeLa cells. Redox Rep 9:302–306
Teicher BA, Linehan WM, Helman LJ (2012) Targeting cancer metabolism. Clin Cancer Res 18:5537–5545
Thompson EW, Haviv I (2011) The social aspects of EMT-MET plasticity. Nat Med 17:1048–1049
Timp W, Feinberg AP (2013) Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 13:497–510
Tiwari N, Gheldof A, Tatari M, Christofori G (2012) EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 22:194–207
Tomasetti M, Neuzil J, Dong L (2013) MicroRNAs as regulators of mitochondrial function: role in cancer suppression. Biochim Biophys Acta 1840:1441–1453
Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML et al (2003) Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95–106
Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E et al (2012) IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483:479–483
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
Vidoni S, Zanna C, Rugolo M, Sarzi E, Lenaers G (2013) Why mitochondria must fuse to maintain their genome integrity. Antioxid Redox Signal 19:379–388
Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8:755–768
Wallace DC (2012) Mitochondria and cancer. Nat Rev Cancer 12:685–698
Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359–407
Wang Y, Shang Y (2013) Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. Exp Cell Res 319:160–169
Warburg O (1956) On the origin of cancer cells. Science 123:309–314
Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21:297–308
Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN et al (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385–1393
Yancovitz M, Litterman A, Yoon J, Ng E, Shapiro RL, Berman RS et al (2012) Intra- and inter-tumor heterogeneity of BRAF(V600E) mutations in primary and metastatic melanoma. PLoS One 7:e29336
Yates LA, Norbury CJ, Gilbert RJ (2013) The long and short of microRNA. Cell 153:516–519
Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302:1–12
Zhang J, Nuebel E, Daley GQ, Koehler CM, Teitell MA (2012) Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell 11:589–595
Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P et al (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324:261–265
Ziv O, Glaser B, Dor Y (2013) The plastic pancreas. Dev Cell 26:3–7
Zu XL, Guppy M (2004) Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 313:459–465
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Wien
About this chapter
Cite this chapter
Berridge, M.V., Herst, P.M. (2015). Tumor Cell Complexity and Metabolic Flexibility in Tumorigenesis and Metastasis. In: Mazurek, S., Shoshan, M. (eds) Tumor Cell Metabolism. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1824-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1824-5_2
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1823-8
Online ISBN: 978-3-7091-1824-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)